Vitamin D

  • Uploaded by: Adrianne Bazo
  • 0
  • 0
  • November 2019
  • PDF

This document was uploaded by user and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this DMCA report form. Report DMCA


Overview

Download & View Vitamin D as PDF for free.

More details

  • Words: 279
  • Pages: 2
NURS 1566 Clinical Form 3: Clinical Medications Worksheets Generic Name Vitamin D

Trade Name Calderol

Classification Dose Route Fat-soluble 400 IU PO vitamin Duration Normal dosage range Unknown 400-1000 IU daily

Peak Unknown

Onset Unknown

Time/frequency Q daily

Why is your patient getting this medication Treatment/management of metabolic bone disease (osteoporosis)

For IV meds, compatibility with IV drips and/or solutions N/A

Mechanism of action and indications (Why med ordered) Promotes absorption of calcium and phosphorus, regulates calcium homeostasis in conjunction with parathyroid hormone and calcitonin.

Nursing Implications (what to focus on) Contraindications/warnings/interactions Hypersensitivity, hypercalcemia/hyperphosphatemia, Vitamin D toxicity Common side effects Seen primarly as manifestations of toxicity (hypercalcemia), headache, somnolence, weakness, dizziness, malaise

Interactions with other patient drugs, OTC or herbal medicines (ask patient specifically) Corticosteroids decrease the effectiveness of Vitamin D analogues

Nursing Process- Assessment (Pre-administration assessment) s/s of vitamin deficiency prior and periodically during therapy. Assess for bone pain and weakness.

Lab value alterations caused by medicine Monitor BUN, serum creatinine, alkaline phosphatase, parathyroid hormone levels, urinary calcium/creatinine ratio, 24 hour urine calcium periodically. A decrease in alkaline phosphatase levels may signal onset of hypercalcemia. May cause false increase of cholesterol levels. Be sure to teach the patient the following about this medication Take only as directed, review diet modifications with pt. Encourage intake of foods that are calcium and vitamin D rich. Do not exceed the RDA. Review s/s of overdose. Emphasize the importance of follow-up exams to monitor progress. Assessment Evaluation Why would you hold or not give this Check after giving med? Normalization of serum s/s of hypocalcemia (paresthesia, calcium and parathyroid muscle twitching, laryngospasm, hormone levels colic, cardiac arrhythmias, and Chostek’s or Trousseau’s sign

Related Documents

Vitamin D
November 2019 16
Vitamin D
May 2020 10
Vitamin D And Cancer
May 2020 12
Vitamin D Deficiency
June 2020 18
Vitamin D And Cancer
June 2020 8
Calcium 600/vitamin D
October 2019 15

More Documents from "E"

Naloxone (narcan)
November 2019 2
Protonix
November 2019 5
Dantrium
November 2019 2
Ertapenem (invanz)
November 2019 5
Tamoxifen Nolvadex
November 2019 2
Morphine (astramorph) Pca
November 2019 16